Targeting tumor architecture to favor drug penetration: a new weapon to combat chemoresistance in pancreatic cancer?
- PMID: 22439929
- DOI: 10.1016/j.ccr.2012.03.002
Targeting tumor architecture to favor drug penetration: a new weapon to combat chemoresistance in pancreatic cancer?
Abstract
Pancreatic ductal adenocarcinoma (PDA) responds poorly to chemotherapy. In this issue of Cancer Cell, Provenzano et al. identify hyaluronan as a pivotal determinant of elevated interstitial fluid pressures (IFP) and vascular collapse in PDA. PEGPH20 treatment ablates stromal hyaluronan, normalizes IFP, and increases accessibility of tumor cells to anticancer drugs.
Copyright © 2012 Elsevier Inc. All rights reserved.
Comment on
-
Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma.Cancer Cell. 2012 Mar 20;21(3):418-29. doi: 10.1016/j.ccr.2012.01.007. Cancer Cell. 2012. PMID: 22439937 Free PMC article.
Similar articles
-
Targeting the Tumor Stroma: the Biology and Clinical Development of Pegylated Recombinant Human Hyaluronidase (PEGPH20).Curr Oncol Rep. 2017 Jul;19(7):47. doi: 10.1007/s11912-017-0608-3. Curr Oncol Rep. 2017. PMID: 28589527 Review.
-
Interstitial Pressure in Pancreatic Ductal Adenocarcinoma Is Dominated by a Gel-Fluid Phase.Biophys J. 2016 May 10;110(9):2106-19. doi: 10.1016/j.bpj.2016.03.040. Biophys J. 2016. PMID: 27166818 Free PMC article.
-
Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse.Cancer Res. 1992 Sep 15;52(18):5110-4. Cancer Res. 1992. PMID: 1516068
-
Non-Invasive Monitoring of Stromal Biophysics with Targeted Depletion of Hyaluronan in Pancreatic Ductal Adenocarcinoma.Cancers (Basel). 2019 Jun 4;11(6):772. doi: 10.3390/cancers11060772. Cancers (Basel). 2019. PMID: 31167451 Free PMC article.
-
Ductal pancreatic cancer in humans and mice.Cold Spring Harb Symp Quant Biol. 2005;70:65-72. doi: 10.1101/sqb.2005.70.040. Cold Spring Harb Symp Quant Biol. 2005. PMID: 16869739 Review.
Cited by
-
Clinical implications of EphB4 receptor expression in pancreatic cancer.Mol Biol Rep. 2013 Feb;40(2):1735-41. doi: 10.1007/s11033-012-2224-5. Epub 2012 Oct 19. Mol Biol Rep. 2013. PMID: 23079712
-
Characterization and verification of CAF-relevant prognostic gene signature to aid therapy in bladder cancer.Heliyon. 2024 Jan 11;10(3):e23873. doi: 10.1016/j.heliyon.2023.e23873. eCollection 2024 Feb 15. Heliyon. 2024. PMID: 38317915 Free PMC article.
-
Global cluster analysis and network visualization in cancer-associated fibroblast: insights from Web of Science database from 1999 to 2021.Eur J Med Res. 2023 Nov 29;28(1):549. doi: 10.1186/s40001-023-01527-3. Eur J Med Res. 2023. PMID: 38031121 Free PMC article.
-
Identification of prognostic genes in the pancreatic adenocarcinoma immune microenvironment by integrated bioinformatics analysis.Cancer Immunol Immunother. 2022 Jul;71(7):1757-1769. doi: 10.1007/s00262-021-03110-3. Epub 2021 Dec 2. Cancer Immunol Immunother. 2022. PMID: 34854950 Free PMC article.
-
Antifibrotic therapy to normalize the tumor microenvironment.J Transl Med. 2020 May 20;18(1):207. doi: 10.1186/s12967-020-02376-y. J Transl Med. 2020. PMID: 32434573 Free PMC article. Review.
Publication types
LinkOut - more resources
Full Text Sources
Molecular Biology Databases